img

Global In Vitro Screening Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global In Vitro Screening Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal In Vitro Screening Market
The global In Vitro Screening market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for In Vitro Screening is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for In Vitro Screening is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for In Vitro Screening is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key companies of In Vitro Screening include Thermo Fisher Scientific, PerkinElmer, Merck, Charles River, Pharmaron, Reaction Biology, Eurofins Discovery, Frontage Laboratories and Atlantic Bone Screen, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for In Vitro Screening market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of In Vitro Screening, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for In Vitro Screening, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the In Vitro Screening revenue, market share and industry ranking of main companies, data from 2018 to 2024. Identification of the major stakeholders in the global In Vitro Screening market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2034. Evaluation and forecast the market size for In Vitro Screening revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Thermo Fisher Scientific, PerkinElmer, Merck, Charles River, Pharmaron, Reaction Biology, Eurofins Discovery, Frontage Laboratories and Atlantic Bone Screen, etc.



By Company


Thermo Fisher Scientific
PerkinElmer
Merck
Charles River
Pharmaron
Reaction Biology
Eurofins Discovery
Frontage Laboratories
Atlantic Bone Screen
Intertek
Visikol
Evotec
Tergus Pharma
QIMA Life Sciences
Wuxi Biortus Biosciences
ICE Bioscience
Viva Biotech
Topscience
Segment by Type
Enzymes
Ion Channels
GPCRs
Nuclear Receptors
Protein-protein Interactions

Segment by Application


Oncology
Immunology
Metabolic Diseases
CNS
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of In Vitro Screening in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of In Vitro Screening companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In Vitro Screening revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Screening Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Enzymes
1.2.3 Ion Channels
1.2.4 GPCRs
1.2.5 Nuclear Receptors
1.2.6 Protein-protein Interactions
1.3 Market by Application
1.3.1 Global In Vitro Screening Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Oncology
1.3.3 Immunology
1.3.4 Metabolic Diseases
1.3.5 CNS
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Screening Market Perspective (2018-2034)
2.2 Global In Vitro Screening Growth Trends by Region
2.2.1 In Vitro Screening Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 In Vitro Screening Historic Market Size by Region (2018-2024)
2.2.3 In Vitro Screening Forecasted Market Size by Region (2024-2034)
2.3 In Vitro Screening Market Dynamics
2.3.1 In Vitro Screening Industry Trends
2.3.2 In Vitro Screening Market Drivers
2.3.3 In Vitro Screening Market Challenges
2.3.4 In Vitro Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue In Vitro Screening by Players
3.1.1 Global In Vitro Screening Revenue by Players (2018-2024)
3.1.2 Global In Vitro Screening Revenue Market Share by Players (2018-2024)
3.2 Global In Vitro Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of In Vitro Screening, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global In Vitro Screening Market Concentration Ratio
3.4.1 Global In Vitro Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Screening Revenue in 2022
3.5 Global Key Players of In Vitro Screening Head office and Area Served
3.6 Global Key Players of In Vitro Screening, Product and Application
3.7 Global Key Players of In Vitro Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Screening Breakdown Data by Type
4.1 Global In Vitro Screening Historic Market Size by Type (2018-2024)
4.2 Global In Vitro Screening Forecasted Market Size by Type (2024-2034)
5 In Vitro Screening Breakdown Data by Application
5.1 Global In Vitro Screening Historic Market Size by Application (2018-2024)
5.2 Global In Vitro Screening Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America In Vitro Screening Market Size (2018-2034)
6.2 North America In Vitro Screening Market Size by Type
6.2.1 North America In Vitro Screening Market Size by Type (2018-2024)
6.2.2 North America In Vitro Screening Market Size by Type (2024-2034)
6.2.3 North America In Vitro Screening Market Share by Type (2018-2034)
6.3 North America In Vitro Screening Market Size by Application
6.3.1 North America In Vitro Screening Market Size by Application (2018-2024)
6.3.2 North America In Vitro Screening Market Size by Application (2024-2034)
6.3.3 North America In Vitro Screening Market Share by Application (2018-2034)
6.4 North America In Vitro Screening Market Size by Country
6.4.1 North America In Vitro Screening Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America In Vitro Screening Market Size by Country (2018-2024)
6.4.3 North America In Vitro Screening Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe In Vitro Screening Market Size (2018-2034)
7.2 Europe In Vitro Screening Market Size by Type
7.2.1 Europe In Vitro Screening Market Size by Type (2018-2024)
7.2.2 Europe In Vitro Screening Market Size by Type (2024-2034)
7.2.3 Europe In Vitro Screening Market Share by Type (2018-2034)
7.3 Europe In Vitro Screening Market Size by Application
7.3.1 Europe In Vitro Screening Market Size by Application (2018-2024)
7.3.2 Europe In Vitro Screening Market Size by Application (2024-2034)
7.3.3 Europe In Vitro Screening Market Share by Application (2018-2034)
7.4 Europe In Vitro Screening Market Size by Country
7.4.1 Europe In Vitro Screening Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe In Vitro Screening Market Size by Country (2018-2024)
7.4.3 Europe In Vitro Screening Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China In Vitro Screening Market Size (2018-2034)
8.2 China In Vitro Screening Market Size by Type
8.2.1 China In Vitro Screening Market Size by Type (2018-2024)
8.2.2 China In Vitro Screening Market Size by Type (2024-2034)
8.2.3 China In Vitro Screening Market Share by Type (2018-2034)
8.3 China In Vitro Screening Market Size by Application
8.3.1 China In Vitro Screening Market Size by Application (2018-2024)
8.3.2 China In Vitro Screening Market Size by Application (2024-2034)
8.3.3 China In Vitro Screening Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia In Vitro Screening Market Size (2018-2034)
9.2 Asia In Vitro Screening Market Size by Type
9.2.1 Asia In Vitro Screening Market Size by Type (2018-2024)
9.2.2 Asia In Vitro Screening Market Size by Type (2024-2034)
9.2.3 Asia In Vitro Screening Market Share by Type (2018-2034)
9.3 Asia In Vitro Screening Market Size by Application
9.3.1 Asia In Vitro Screening Market Size by Application (2018-2024)
9.3.2 Asia In Vitro Screening Market Size by Application (2024-2034)
9.3.3 Asia In Vitro Screening Market Share by Application (2018-2034)
9.4 Asia In Vitro Screening Market Size by Region
9.4.1 Asia In Vitro Screening Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia In Vitro Screening Market Size by Region (2018-2024)
9.4.3 Asia In Vitro Screening Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America In Vitro Screening Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America In Vitro Screening Market Size by Type
10.2.1 Middle East, Africa, and Latin America In Vitro Screening Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America In Vitro Screening Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America In Vitro Screening Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America In Vitro Screening Market Size by Application
10.3.1 Middle East, Africa, and Latin America In Vitro Screening Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America In Vitro Screening Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America In Vitro Screening Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America In Vitro Screening Market Size by Country
10.4.1 Middle East, Africa, and Latin America In Vitro Screening Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America In Vitro Screening Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America In Vitro Screening Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific In Vitro Screening Introduction
11.1.4 Thermo Fisher Scientific Revenue in In Vitro Screening Business (2018-2024)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 PerkinElmer
11.2.1 PerkinElmer Company Details
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer In Vitro Screening Introduction
11.2.4 PerkinElmer Revenue in In Vitro Screening Business (2018-2024)
11.2.5 PerkinElmer Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck In Vitro Screening Introduction
11.3.4 Merck Revenue in In Vitro Screening Business (2018-2024)
11.3.5 Merck Recent Developments
11.4 Charles River
11.4.1 Charles River Company Details
11.4.2 Charles River Business Overview
11.4.3 Charles River In Vitro Screening Introduction
11.4.4 Charles River Revenue in In Vitro Screening Business (2018-2024)
11.4.5 Charles River Recent Developments
11.5 Pharmaron
11.5.1 Pharmaron Company Details
11.5.2 Pharmaron Business Overview
11.5.3 Pharmaron In Vitro Screening Introduction
11.5.4 Pharmaron Revenue in In Vitro Screening Business (2018-2024)
11.5.5 Pharmaron Recent Developments
11.6 Reaction Biology
11.6.1 Reaction Biology Company Details
11.6.2 Reaction Biology Business Overview
11.6.3 Reaction Biology In Vitro Screening Introduction
11.6.4 Reaction Biology Revenue in In Vitro Screening Business (2018-2024)
11.6.5 Reaction Biology Recent Developments
11.7 Eurofins Discovery
11.7.1 Eurofins Discovery Company Details
11.7.2 Eurofins Discovery Business Overview
11.7.3 Eurofins Discovery In Vitro Screening Introduction
11.7.4 Eurofins Discovery Revenue in In Vitro Screening Business (2018-2024)
11.7.5 Eurofins Discovery Recent Developments
11.8 Frontage Laboratories
11.8.1 Frontage Laboratories Company Details
11.8.2 Frontage Laboratories Business Overview
11.8.3 Frontage Laboratories In Vitro Screening Introduction
11.8.4 Frontage Laboratories Revenue in In Vitro Screening Business (2018-2024)
11.8.5 Frontage Laboratories Recent Developments
11.9 Atlantic Bone Screen
11.9.1 Atlantic Bone Screen Company Details
11.9.2 Atlantic Bone Screen Business Overview
11.9.3 Atlantic Bone Screen In Vitro Screening Introduction
11.9.4 Atlantic Bone Screen Revenue in In Vitro Screening Business (2018-2024)
11.9.5 Atlantic Bone Screen Recent Developments
11.10 Intertek
11.10.1 Intertek Company Details
11.10.2 Intertek Business Overview
11.10.3 Intertek In Vitro Screening Introduction
11.10.4 Intertek Revenue in In Vitro Screening Business (2018-2024)
11.10.5 Intertek Recent Developments
11.11 Visikol
11.11.1 Visikol Company Details
11.11.2 Visikol Business Overview
11.11.3 Visikol In Vitro Screening Introduction
11.11.4 Visikol Revenue in In Vitro Screening Business (2018-2024)
11.11.5 Visikol Recent Developments
11.12 Evotec
11.12.1 Evotec Company Details
11.12.2 Evotec Business Overview
11.12.3 Evotec In Vitro Screening Introduction
11.12.4 Evotec Revenue in In Vitro Screening Business (2018-2024)
11.12.5 Evotec Recent Developments
11.13 Tergus Pharma
11.13.1 Tergus Pharma Company Details
11.13.2 Tergus Pharma Business Overview
11.13.3 Tergus Pharma In Vitro Screening Introduction
11.13.4 Tergus Pharma Revenue in In Vitro Screening Business (2018-2024)
11.13.5 Tergus Pharma Recent Developments
11.14 QIMA Life Sciences
11.14.1 QIMA Life Sciences Company Details
11.14.2 QIMA Life Sciences Business Overview
11.14.3 QIMA Life Sciences In Vitro Screening Introduction
11.14.4 QIMA Life Sciences Revenue in In Vitro Screening Business (2018-2024)
11.14.5 QIMA Life Sciences Recent Developments
11.15 Wuxi Biortus Biosciences
11.15.1 Wuxi Biortus Biosciences Company Details
11.15.2 Wuxi Biortus Biosciences Business Overview
11.15.3 Wuxi Biortus Biosciences In Vitro Screening Introduction
11.15.4 Wuxi Biortus Biosciences Revenue in In Vitro Screening Business (2018-2024)
11.15.5 Wuxi Biortus Biosciences Recent Developments
11.16 ICE Bioscience
11.16.1 ICE Bioscience Company Details
11.16.2 ICE Bioscience Business Overview
11.16.3 ICE Bioscience In Vitro Screening Introduction
11.16.4 ICE Bioscience Revenue in In Vitro Screening Business (2018-2024)
11.16.5 ICE Bioscience Recent Developments
11.17 Viva Biotech
11.17.1 Viva Biotech Company Details
11.17.2 Viva Biotech Business Overview
11.17.3 Viva Biotech In Vitro Screening Introduction
11.17.4 Viva Biotech Revenue in In Vitro Screening Business (2018-2024)
11.17.5 Viva Biotech Recent Developments
11.18 Topscience
11.18.1 Topscience Company Details
11.18.2 Topscience Business Overview
11.18.3 Topscience In Vitro Screening Introduction
11.18.4 Topscience Revenue in In Vitro Screening Business (2018-2024)
11.18.5 Topscience Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global In Vitro Screening Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Enzymes
Table 3. Key Players of Ion Channels
Table 4. Key Players of GPCRs
Table 5. Key Players of Nuclear Receptors
Table 6. Key Players of Protein-protein Interactions
Table 7. Global In Vitro Screening Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 8. Global In Vitro Screening Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 9. Global In Vitro Screening Market Size by Region (2018-2024) & (US$ Million)
Table 10. Global In Vitro Screening Market Share by Region (2018-2024)
Table 11. Global In Vitro Screening Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 12. Global In Vitro Screening Market Share by Region (2024-2034)
Table 13. In Vitro Screening Market Trends
Table 14. In Vitro Screening Market Drivers
Table 15. In Vitro Screening Market Challenges
Table 16. In Vitro Screening Market Restraints
Table 17. Global In Vitro Screening Revenue by Players (2018-2024) & (US$ Million)
Table 18. Global In Vitro Screening Revenue Share by Players (2018-2024)
Table 19. Global Top In Vitro Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Screening as of 2022)
Table 20. Global In Vitro Screening Industry Ranking 2021 VS 2022 VS 2024
Table 21. Global 5 Largest Players Market Share by In Vitro Screening Revenue (CR5 and HHI) & (2018-2024)
Table 22. Global Key Players of In Vitro Screening, Headquarters and Area Served
Table 23. Global Key Players of In Vitro Screening, Product and Application
Table 24. Global Key Players of In Vitro Screening, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global In Vitro Screening Market Size by Type (2018-2024) & (US$ Million)
Table 27. Global In Vitro Screening Revenue Market Share by Type (2018-2024)
Table 28. Global In Vitro Screening Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 29. Global In Vitro Screening Revenue Market Share by Type (2024-2034)
Table 30. Global In Vitro Screening Market Size by Application (2018-2024) & (US$ Million)
Table 31. Global In Vitro Screening Revenue Share by Application (2018-2024)
Table 32. Global In Vitro Screening Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 33. Global In Vitro Screening Revenue Share by Application (2024-2034)
Table 34. North America In Vitro Screening Market Size by Type (2018-2024) & (US$ Million)
Table 35. North America In Vitro Screening Market Size by Type (2024-2034) & (US$ Million)
Table 36. North America In Vitro Screening Market Size by Application (2018-2024) & (US$ Million)
Table 37. North America In Vitro Screening Market Size by Application (2024-2034) & (US$ Million)
Table 38. North America In Vitro Screening Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 39. North America In Vitro Screening Market Size by Country (2018-2024) & (US$ Million)
Table 40. North America In Vitro Screening Market Size by Country (2024-2034) & (US$ Million)
Table 41. Europe In Vitro Screening Market Size by Type (2018-2024) & (US$ Million)
Table 42. Europe In Vitro Screening Market Size by Type (2024-2034) & (US$ Million)
Table 43. Europe In Vitro Screening Market Size by Application (2018-2024) & (US$ Million)
Table 44. Europe In Vitro Screening Market Size by Application (2024-2034) & (US$ Million)
Table 45. Europe In Vitro Screening Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 46. Europe In Vitro Screening Market Size by Country (2018-2024) & (US$ Million)
Table 47. Europe In Vitro Screening Market Size by Country (2024-2034) & (US$ Million)
Table 48. China In Vitro Screening Market Size by Type (2018-2024) & (US$ Million)
Table 49. China In Vitro Screening Market Size by Type (2024-2034) & (US$ Million)
Table 50. China In Vitro Screening Market Size by Application (2018-2024) & (US$ Million)
Table 51. China In Vitro Screening Market Size by Application (2024-2034) & (US$ Million)
Table 52. Asia In Vitro Screening Market Size by Type (2018-2024) & (US$ Million)
Table 53. Asia In Vitro Screening Market Size by Type (2024-2034) & (US$ Million)
Table 54. Asia In Vitro Screening Market Size by Application (2018-2024) & (US$ Million)
Table 55. Asia In Vitro Screening Market Size by Application (2024-2034) & (US$ Million)
Table 56. Asia In Vitro Screening Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 57. Asia In Vitro Screening Market Size by Region (2018-2024) & (US$ Million)
Table 58. Asia In Vitro Screening Market Size by Region (2024-2034) & (US$ Million)
Table 59. Middle East, Africa, and Latin America In Vitro Screening Market Size by Type (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America In Vitro Screening Market Size by Type (2024-2034) & (US$ Million)
Table 61. Middle East, Africa, and Latin America In Vitro Screening Market Size by Application (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America In Vitro Screening Market Size by Application (2024-2034) & (US$ Million)
Table 63. Middle East, Africa, and Latin America In Vitro Screening Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 64. Middle East, Africa, and Latin America In Vitro Screening Market Size by Country (2018-2024) & (US$ Million)
Table 65. Middle East, Africa, and Latin America In Vitro Screening Market Size by Country (2024-2034) & (US$ Million)
Table 66. Thermo Fisher Scientific Company Details
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific In Vitro Screening Product
Table 69. Thermo Fisher Scientific Revenue in In Vitro Screening Business (2018-2024) & (US$ Million)
Table 70. Thermo Fisher Scientific Recent Developments
Table 71. PerkinElmer Company Details
Table 72. PerkinElmer Business Overview
Table 73. PerkinElmer In Vitro Screening Product
Table 74. PerkinElmer Revenue in In Vitro Screening Business (2018-2024) & (US$ Million)
Table 75. PerkinElmer Recent Developments
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck In Vitro Screening Product
Table 79. Merck Revenue in In Vitro Screening Business (2018-2024) & (US$ Million)
Table 80. Merck Recent Developments
Table 81. Charles River Company Details
Table 82. Charles River Business Overview
Table 83. Charles River In Vitro Screening Product
Table 84. Charles River Revenue in In Vitro Screening Business (2018-2024) & (US$ Million)
Table 85. Charles River Recent Developments
Table 86. Pharmaron Company Details
Table 87. Pharmaron Business Overview
Table 88. Pharmaron In Vitro Screening Product
Table 89. Pharmaron Revenue in In Vitro Screening Business (2018-2024) & (US$ Million)
Table 90. Pharmaron Recent Developments
Table 91. Reaction Biology Company Details
Table 92. Reaction Biology Business Overview
Table 93. Reaction Biology In Vitro Screening Product
Table 94. Reaction Biology Revenue in In Vitro Screening Business (2018-2024) & (US$ Million)
Table 95. Reaction Biology Recent Developments
Table 96. Eurofins Discovery Company Details
Table 97. Eurofins Discovery Business Overview
Table 98. Eurofins Discovery In Vitro Screening Product
Table 99. Eurofins Discovery Revenue in In Vitro Screening Business (2018-2024) & (US$ Million)
Table 100. Eurofins Discovery Recent Developments
Table 101. Frontage Laboratories Company Details
Table 102. Frontage Laboratories Business Overview
Table 103. Frontage Laboratories In Vitro Screening Product
Table 104. Frontage Laboratories Revenue in In Vitro Screening Business (2018-2024) & (US$ Million)
Table 105. Frontage Laboratories Recent Developments
Table 106. Atlantic Bone Screen Company Details
Table 107. Atlantic Bone Screen Business Overview
Table 108. Atlantic Bone Screen In Vitro Screening Product
Table 109. Atlantic Bone Screen Revenue in In Vitro Screening Business (2018-2024) & (US$ Million)
Table 110. Atlantic Bone Screen Recent Developments
Table 111. Intertek Company Details
Table 112. Intertek Business Overview
Table 113. Intertek In Vitro Screening Product
Table 114. Intertek Revenue in In Vitro Screening Business (2018-2024) & (US$ Million)
Table 115. Intertek Recent Developments
Table 116. Visikol Company Details
Table 117. Visikol Business Overview
Table 118. Visikol In Vitro Screening Product
Table 119. Visikol Revenue in In Vitro Screening Business (2018-2024) & (US$ Million)
Table 120. Visikol Recent Developments
Table 121. Evotec Company Details
Table 122. Evotec Business Overview
Table 123. Evotec In Vitro Screening Product
Table 124. Evotec Revenue in In Vitro Screening Business (2018-2024) & (US$ Million)
Table 125. Evotec Recent Developments
Table 126. Tergus Pharma Company Details
Table 127. Tergus Pharma Business Overview
Table 128. Tergus Pharma In Vitro Screening Product
Table 129. Tergus Pharma Revenue in In Vitro Screening Business (2018-2024) & (US$ Million)
Table 130. Tergus Pharma Recent Developments
Table 131. QIMA Life Sciences Company Details
Table 132. QIMA Life Sciences Business Overview
Table 133. QIMA Life Sciences In Vitro Screening Product
Table 134. QIMA Life Sciences Revenue in In Vitro Screening Business (2018-2024) & (US$ Million)
Table 135. QIMA Life Sciences Recent Developments
Table 136. Wuxi Biortus Biosciences Company Details
Table 137. Wuxi Biortus Biosciences Business Overview
Table 138. Wuxi Biortus Biosciences In Vitro Screening Product
Table 139. Wuxi Biortus Biosciences Revenue in In Vitro Screening Business (2018-2024) & (US$ Million)
Table 140. Wuxi Biortus Biosciences Recent Developments
Table 141. ICE Bioscience Company Details
Table 142. ICE Bioscience Business Overview
Table 143. ICE Bioscience In Vitro Screening Product
Table 144. ICE Bioscience Revenue in In Vitro Screening Business (2018-2024) & (US$ Million)
Table 145. ICE Bioscience Recent Developments
Table 146. Viva Biotech Company Details
Table 147. Viva Biotech Business Overview
Table 148. Viva Biotech In Vitro Screening Product
Table 149. Viva Biotech Revenue in In Vitro Screening Business (2018-2024) & (US$ Million)
Table 150. Viva Biotech Recent Developments
Table 151. Topscience Company Details
Table 152. Topscience Business Overview
Table 153. Topscience In Vitro Screening Product
Table 154. Topscience Revenue in In Vitro Screening Business (2018-2024) & (US$ Million)
Table 155. Topscience Recent Developments
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In Vitro Screening Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global In Vitro Screening Market Share by Type: 2022 VS 2034
Figure 3. Enzymes Features
Figure 4. Ion Channels Features
Figure 5. GPCRs Features
Figure 6. Nuclear Receptors Features
Figure 7. Protein-protein Interactions Features
Figure 8. Global In Vitro Screening Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global In Vitro Screening Market Share by Application: 2022 VS 2034
Figure 10. Oncology Case Studies
Figure 11. Immunology Case Studies
Figure 12. Metabolic Diseases Case Studies
Figure 13. CNS Case Studies
Figure 14. Others Case Studies
Figure 15. In Vitro Screening Report Years Considered
Figure 16. Global In Vitro Screening Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 17. Global In Vitro Screening Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 18. Global In Vitro Screening Market Share by Region: 2022 VS 2034
Figure 19. Global In Vitro Screening Market Share by Players in 2022
Figure 20. Global Top In Vitro Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Screening as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by In Vitro Screening Revenue in 2022
Figure 22. North America In Vitro Screening Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. North America In Vitro Screening Market Share by Type (2018-2034)
Figure 24. North America In Vitro Screening Market Share by Application (2018-2034)
Figure 25. North America In Vitro Screening Market Share by Country (2018-2034)
Figure 26. United States In Vitro Screening Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Canada In Vitro Screening Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Europe In Vitro Screening Market Size YoY (2018-2034) & (US$ Million)
Figure 29. Europe In Vitro Screening Market Share by Type (2018-2034)
Figure 30. Europe In Vitro Screening Market Share by Application (2018-2034)
Figure 31. Europe In Vitro Screening Market Share by Country (2018-2034)
Figure 32. Germany In Vitro Screening Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. France In Vitro Screening Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. U.K. In Vitro Screening Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Italy In Vitro Screening Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Russia In Vitro Screening Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Nordic Countries In Vitro Screening Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. China In Vitro Screening Market Size YoY (2018-2034) & (US$ Million)
Figure 39. China In Vitro Screening Market Share by Type (2018-2034)
Figure 40. China In Vitro Screening Market Share by Application (2018-2034)
Figure 41. Asia In Vitro Screening Market Size YoY (2018-2034) & (US$ Million)
Figure 42. Asia In Vitro Screening Market Share by Type (2018-2034)
Figure 43. Asia In Vitro Screening Market Share by Application (2018-2034)
Figure 44. Asia In Vitro Screening Market Share by Region (2018-2034)
Figure 45. Japan In Vitro Screening Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. South Korea In Vitro Screening Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. China Taiwan In Vitro Screening Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Southeast Asia In Vitro Screening Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 49. India In Vitro Screening Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 50. Australia In Vitro Screening Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America In Vitro Screening Market Size YoY (2018-2034) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America In Vitro Screening Market Share by Type (2018-2034)
Figure 53. Middle East, Africa, and Latin America In Vitro Screening Market Share by Application (2018-2034)
Figure 54. Middle East, Africa, and Latin America In Vitro Screening Market Share by Country (2018-2034)
Figure 55. Brazil In Vitro Screening Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 56. Mexico In Vitro Screening Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 57. Turkey In Vitro Screening Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 58. Saudi Arabia In Vitro Screening Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 59. Israel In Vitro Screening Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 60. GCC Countries In Vitro Screening Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in In Vitro Screening Business (2018-2024)
Figure 62. PerkinElmer Revenue Growth Rate in In Vitro Screening Business (2018-2024)
Figure 63. Merck Revenue Growth Rate in In Vitro Screening Business (2018-2024)
Figure 64. Charles River Revenue Growth Rate in In Vitro Screening Business (2018-2024)
Figure 65. Pharmaron Revenue Growth Rate in In Vitro Screening Business (2018-2024)
Figure 66. Reaction Biology Revenue Growth Rate in In Vitro Screening Business (2018-2024)
Figure 67. Eurofins Discovery Revenue Growth Rate in In Vitro Screening Business (2018-2024)
Figure 68. Frontage Laboratories Revenue Growth Rate in In Vitro Screening Business (2018-2024)
Figure 69. Atlantic Bone Screen Revenue Growth Rate in In Vitro Screening Business (2018-2024)
Figure 70. Intertek Revenue Growth Rate in In Vitro Screening Business (2018-2024)
Figure 71. Visikol Revenue Growth Rate in In Vitro Screening Business (2018-2024)
Figure 72. Evotec Revenue Growth Rate in In Vitro Screening Business (2018-2024)
Figure 73. Tergus Pharma Revenue Growth Rate in In Vitro Screening Business (2018-2024)
Figure 74. QIMA Life Sciences Revenue Growth Rate in In Vitro Screening Business (2018-2024)
Figure 75. Wuxi Biortus Biosciences Revenue Growth Rate in In Vitro Screening Business (2018-2024)
Figure 76. ICE Bioscience Revenue Growth Rate in In Vitro Screening Business (2018-2024)
Figure 77. Viva Biotech Revenue Growth Rate in In Vitro Screening Business (2018-2024)
Figure 78. Topscience Revenue Growth Rate in In Vitro Screening Business (2018-2024)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed